This target site is located outside of known protein coding domains that are associated with BRCA1 loss of function in human cancers when mutated, which in turn suggests the possibility of additional mechanisms through which activity of this crucial regulator of genomic integrity may be suppressed in human disease (Fackenthal and Olopade, 2007). Here, BRCA1 is linked to cancer.